Pros use pills to boost brainpower

Fuzzy-headed today? Then pop a pill. Professionals of all kinds are doing it these days, according to a survey taken by Nature. Young, old, you name it--they're taking various meds to boost their concentration and memory. Some 62 percent prefer Ritalin, the ADHD med made by Novartis. Another 44 percent liked Cephlon's Provigil, the "keep-awake" drug. Others used Adderall or another amphetamine, beta blockers, even centrophenoxine, a dementia med.

Now, the survey was open only to Nature subscribers, who tend to be scientists, engineers, or folks like journalists who follow science closely. So it's not a generalized, randomized bit of research. (Of the 1,400-odd people who responded, about 15 percent were biologists and 15 percent engineers; 12 percent were educators, 8 percent worked in the medical field, and 7 percent in the media.) But it does show a clear trend.

Another thing: Almost 80 percent of the respondents said healthy people should be allowed to take cognitive-enhancing drugs if they choose. But even more--86 percent--felt that kids under 16 shouldn't be on any of these meds.

- read the Washington Post story
- check out the item in the WSJ Health Blog

Related Articles:
Provigil study sparks debate over ability to enhance alertness
Provigil--Top 10 Warnings and Recalls
Study: Teens abusing prescription drugs
FDA panel wants 'black box' on ADHD drugs

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.